作者
Alnada Abdalla Mohamed Ibrahim, Amal Almotiry Alshatri, Salem Alsuwaidan, Lulu Almutairi, Nasser Aljasser, Mansour Adam Mahmoud, Afnan Alaseeri, Abrar Almonysir, Badraa Alotaibi, Batoul Alrasheed, Maram Alfawaz
发表日期
2021/6/1
期刊
Saudi Pharmaceutical Journal
卷号
29
期号
6
页码范围
527-532
出版商
Elsevier
简介
Introduction
Oral isotretinoin is an effective agent for the treatment of severe cystic acne. Isotretinoin is a teratogen; there is an increased risk of congenital defects in infants exposed to the drug in the uterus. The Saudi Food and Drug Authority (SFDA) has implemented a pregnancy prevention program (PPP) to protect females from those teratogenic effects.
Objectives
To investigate the awareness of women, of reproductive age who were using Isotretinoin or used it previously, about isotretinoin use and the SFDA-approved PPP in Riyadh, Saudi Arabia.
Methods
This cross-sectional study was conducted during the period from June to October 2019. A questionnaire was developed based on the published literature and the PPP recommendations. The study was carried out online among female patients who were on Isotretinoin therapy or have used it previously in Riyadh city. The Statistical Package for Social Sciences …
学术搜索中的文章
AAM Ibrahim, AA Alshatri, S Alsuwaidan, L Almutairi… - Saudi Pharmaceutical Journal, 2021